Ian Cooper

Ian Cooper

InvestorPlace Contributor

Ian Cooper has helped traders grow and protect their wealth since 1999.

Over the last 24 years, he’s taught thousands of investors how to trade news flow and herd mentality using a unique blend of technical and fundamental analysis. In fact, Cooper created the ADD News Flow Strategy, which allows us to trade the anticipation, dissemination, and the death of news flow by exploiting herd mentality.

Cooper was among the few analysts to spot the financial crisis of 2008, the top of subprime and Alt-A, the death of Lehman Brothers, Bear Stearns, and New Century Financial, and even the Dow’s collapse to 6,500, as well as its recovery. He even called for gold to rally well above $1.500 when it traded under $600.

At the moment, Cooper makes use of technical, fundamental and news analysis, to help individual investors grow their wealth. He’s a firm believer that hard work and thorough research will lead to investment success.

Recent Articles

7 EV Stocks to Make Your ‘Get Rich’ Dreams Come True

By Ian Cooper, InvestorPlace Contributor

The electric vehicle boom is accelerating – with no signs of slowing down. So, it just makes sense to look at how to get rich with EV stocks.

3 AI Stocks to Make Your ‘Get Rich’ Dreams Come True

By Ian Cooper, InvestorPlace Contributor

Artificial intelligence (AI) will be one of the decade's biggest stories, creating a big opportunity for these top AI stocks to buy.

3 Penny Stocks to Make Your ‘Get Rich’ Dreams Come True

By Ian Cooper, InvestorPlace Contributor

When it comes to potentially profitable penny stocks, some can create unimaginable fortunes for patient investors. Others, not so much.

The 3 Best Metaverse Stocks to Buy in July

By Ian Cooper, InvestorPlace Contributor

It’s time to bet big again on best metaverse stocks in July. In fact, here are three of the top ways to trade its reemergence.

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023

By Ian Cooper, InvestorPlace Contributor

If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

Load More